Name: Latest research reports of Torrent Pharmaceuticals Ltd. authored by Motilal Oswal and published by - Trendlyne research reports.
Item: Torrent Pharmaceuticals Ltd.
Rating: 3
Author: Motilal Oswal

Torrent Pharmaceuticals Ltd.

NSE: TORNTPHARM | BSE: 500420 | ISIN: INE685A01028 | Industry: Pharmaceuticals
| Expensive Performer

3816.6000 -5.50 (-0.14%)

NSE Dec 31, 2025 11:27 AM

Near 52W High of ₹3882.20

Volume: 20,223

Torrent Pharmaceuticals Ltd.

23 Jul 2024

3816.60

-0.14%

India/Germany businesses drive earnings

Neutral: Torrent Pharmaceuticals Ltd.

Target

Motilal Oswal

Torrent Pharma (TRP) delivered largely in-line 1QFY25. TRP posted robust 14.7% YoY growth in domestic formulation (DF) segment.

Torrent Pharmaceutic.. has an average target of 3880.00 from 6 brokers.